Metrika članka

  • citati u SCindeksu: [1]
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:5
  • preuzimanja u poslednjih 30 dana:3
članak: 3 od 43  
Back povratak na rezultate
Vojnosanitetski pregled
2018, vol. 75, br. 3, str. 267-272
jezik rada: engleski
vrsta rada: izvorni naučni članak
objavljeno: 31/05/2018
doi: 10.2298/VSP160314204V
Creative Commons License 4.0
Povezanost nivoa 25-hidroksivitamina D [25(OH)D] i mesta stanovanja bolesnika sa multiplom sklerozom u Crnoj Gori - viši nivoi samo kod muškaraca na severu zemlje
aClinical Centre of Montenegro, Clinical Department of Neurology, Podgorica, Montenegro + University of Montenegro, Faculty of Medicine, Podgorica, Montenegro
bThe Neurology Outpatients Clinic 'Neuron', Bijelo Polje, Montenegro

e-adresa: slavica.vujisic@kccg.me

Sažetak

Uvod/Cilj. Multipla skleroza (MS) je hronična neurološka bolest, povezana s niskim serumskim nivoom 25-hidroksivitamina D [25 (OH)D]. Cilj rada bio je da se ispitaju povezanost nivoa 25(OH)D u serumu sa geografskom širinom mesta boravka obolelih i onesposobljenošču i progresijom MS, izraženim preko proširenog skora stepena onesposobljenost (EDSS) i stepena spasticiteta obolelih od multiple skleroze (MSSS). Metode. U studiju je bilo uključeno ukupno 196 bolesnika sa severa i juga Crne Gore, starosti između 18 i 65 godina, sa definitivnom dijagnozom MS. Od svakog pojedinačnog bolesnika je na dan prijema uziman serum za analizu nivoa 25(OH)D. Kontrolna grupa se sastojala od 196 zdravih ispitanika, koji su metodom slučajnog uzorka birani među medicinskim osobljem tri bolnice sa severa i Kliničkog centra Crne Gore, sa juga zemlje. Rezultati. Nivoi serumskog 25(OH)D bili su značajno niži kod bolesnika sa MS u odnosu na kontrolnu grupu (p < 0.001). Nivo 25(OH)D značajno se razlikovao u odnosu na pol, pri čemu su kod žena registrovani niži nivoi. Mada kod svih ispitanika nije zabeležena statistički značajna korelacija između nivoa 25(OH)D i prebivališta, nađen je značajno viši nivo 25(OH)D kod muškaraca sa severa u odnosu na žene. Tok bolesti je uticao na nivo 25(OH)D u serumu. Nivo 25(OH)D bio je u značajnoj korelaciji sa kliničkom nesposobnošću (Spearmanov r = -0.23, p = 0.001) i progresijom bolesti (Spearmanov r = -0.25, p = 0.0004). Zaključak. Serumske koncentracije 25(OH)D povezane su sa nesposobnošću i napredovanjem bolesti kod bolesnika sa MS. Niži nivoi 25(OH)D nađeni su kod žena sa severa. Nađene niske koncentracije 25(OH)D ne mogu se objasniti samo geografskom širinom i nedovoljnim izlaganjem suncu, zbog čega su potrebna dalja genetska istraživanja.

Ključne reči

Reference

Ascherio, A., Munger, K.L., White, R., Köchert, K., Simon, K.C., Polman, C.H., Freedman, M.S., Hartung, H., Miller, D.H., Montalbán, X., Edan, G., Barkhof, F., Pleimes, D., Radü, E. (2014) Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression. JAMA Neurology, 71(3): 306
Auer, D.P., Schumann, E.M., Kümpfel, T., Gössl, C., Trenkwalder, C. (2000) Seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis. Annals of Neurology, 47(2): 276-277
Cantorna, M.T. (2008) Vitamin D and multiple sclerosis: an update. Nutrition Reviews, 66: S135-S138
Correale, J., Ysrraelit, M.C., Gaitan, M.I. (2009) Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain, 132(5): 1146-1160
Daroff, R.B., Fenichel, G.M., Janković, J., Mazziotta, J.C. (2012) Bradley's neurology in clinical practice. Philadelphia: Elsevier Saunders, 6th ed
Dobson, R., Giovannoni, G., Ramagopalan, S. (2013) The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. Journal of Neurology, Neurosurgery & Psychiatry, 84(4): 427-432
Hagenau, T., Vest, R., Gissel, T.N., Poulsen, C.S., Erlandsen, M., Mosekilde, L., Vestergaard, P. (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporosis International, 20(1): 133-140
Hatamian, H., Bidabadi, E., Seyed, S.S.M., Saadat, N.S., Kazemnezhad, E., Ramezani, H. (2013) Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?. Iran J Neurol, 12(2), 41−46
Hayes, C.E., Hubler, S.L., Moore, J.R., Barta, L.E., Praska, C.E., Nashold, F.E. (2015) Vitamin D Actions on CD4+ T Cells in Autoimmune Disease. Frontiers in Immunology, 6: 100
Holick, M.F., Chen, T.C. (2008) Vitamin D deficiency: a worldwide problem with health consequences. American Journal of Clinical Nutrition, 87(4): 1080S-1086S
Hydrometeorological Institute of Montenegro (2016) homepage on the Internet, http://www.meteo.co.me/misc.php?text=128&sektor=1, 2016 Feb 2
Kampman, M.T., Brustad, M. (2008) Vitamin D: A Candidate for the Environmental Effect in Multiple Sclerosis – Observations from Norway. Neuroepidemiology, 30(3): 140-146
Kragt, J., van Amerongen, B., Killestein, J., Dijkstra, C., Uitdehaag, B., Polman, C., Lips, P. (2009) Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Multiple Sclerosis Journal, 15(1): 9-15
Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11): 1444-52
Langlois, K., Greene-Finestone, L., Little, J., Hidiroglou, N., Whiting, S. (2010) Vitamin D status of Canadians as measured in the 2007 to 2009 Canadian Health Measures Survey. Health Rep, 21(1): 47-55
Linhares, E.R., Jones, D.A., Round, J.M., Edwards, R.H.T. (1984) Effect of nutrition on vitamin D status: studies on healthy and poorly nourished Brazilian children. American Journal of Clinical Nutrition, 39(4): 625-630
Lips, P. (2010) Worldwide status of vitamin D nutrition. Journal of Steroid Biochemistry and Molecular Biology, 121(1-2): 297-300
Mcdonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van den Noort, S., Weinshenker, B.Y., Wolinsky, J.S. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol, 50(1): 121-7
Pierrot-Deseilligny, C., Souberbielle, J.-C. (2010) Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?. Brain, 133(7): 1869-1888
Pugliatti, M., Sotgiu, S., Rosati, G. (2002) The worldwide prevalence of multiple sclerosis. Clinical Neurology and Neurosurgery, 104(3): 182-191
Rockell, J.E.P., Skeaff, C.M., Williams, S.M., Green, T.J. (2006) Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporosis International, 17(9): 1382-1389
Roxburgh, R.H.S.R., Seaman, S.R., Masterman, T., Hensiek, A.E., Sawcer, S.J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., Edan, G., McDonnell, G.V., Hawkins, S., Trojano, M., Liguori, M., Cocco, E., i dr. (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology, 64(7): 1144-51
Smolders, J., Menheere, P., Kessels, A., Damoiseaux, J., Hupperts, R. (2008) Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Multiple Sclerosis Journal, 14(9): 1220-1224
Smolders, J., Menheere, P., Thewissen, M., Peelen, E., Tervaert, J.W.C., Hupperts, R., Damoiseaux, J. (2010) Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. Journal of Steroid Biochemistry and Molecular Biology, 121(1-2): 243-246
Soilu-Hänninen, M., Airas, L., Mononen, I., Heikkilä, A., Viljanen, M., Hänninen, A. (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Multiple Sclerosis Journal, 11(3): 266-271
Välimäki, V., Löyttyniemi, E., Välimäki, M.J. (2007) Vitamin D fortification of milk products does not resolve hypovitaminosis D in young Finnish men. European Journal of Clinical Nutrition, 61(4): 493-497
van der Mei, I.A.F. (2003) Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ, 327(7410): 316-0
van der Mei, I.A.F., Ponsonby, A., Engelsen, O., Pasco, J.A., McGrath, J.J., Eyles, D.W., Blizzard, L., Dwyer, T., Lucas, R., Jones, G. (2007) The High Prevalence of Vitamin D Insufficiency across Australian Populations Is Only Partly Explained by Season and Latitude. Environmental Health Perspectives, 115(8): 1132-1139
Webb, A.R., Kline, L., Holick, M.F. (1988) Influence of Season and Latitude on the Cutaneous Synthesis of Vitamin D 3 : Exposure to Winter Sunlight in Boston and Edmonton Will Not Promote Vitamin D 3 Synthesis in Huma. Journal of Clinical Endocrinology & Metabolism, 67(2): 373-378
Weinstock-Guttman, B., Zivadinov, R., Qu, J., Cookfair, D., Duan, X., Bang, E., Bergsland, N., Hussein, S., Cherneva, M., Willis, L., Heininen-Brown, M., Ramanathan, M. (2011) Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. Journal of Neurology, Neurosurgery & Psychiatry, 82(2): 189-195
Zadshir, A., Tareen, N., Pan, D., Norris, K., Martins, D. (2005) The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis, 15(4 Suppl 5): S5-97-101